AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
19 hedge funds and large institutions have $56.4M invested in Agile Therapeutics in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
19
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$479K | |
| 2 | +$216K | |
| 3 | +$77.2K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$77.2K |
| 5 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$61.8K |
Top Sellers
| 1 | -$1.17M | |
| 2 | -$975K | |
| 3 | -$943K | |
| 4 |
Morgan Stanley
New York
|
-$232K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$216K |